Serum lipoprotein-associated phospholipase A2 level is positively correlated with the recurrence risk of acute ischemic cerebral infarction in hypertensive patients.
10.12122/j.issn.1673-4254.2023.02.22
- Author:
Li Bing LIANG
1
;
Jing Juan CHEN
2
;
Cheng Guo ZHANG
2
;
Yu Kai WANG
2
;
Bai Gui LUO
3
;
Tian En ZHOU
4
;
Xiao Feng WANG
1
Author Information
1. Department of Neurology, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510630, China.
2. Department of Neurology, The Foshan First People's Hospital, Foshan 528000, China.
3. Science and Education Department, The Foshan First People's Hospital, Foshan 528000, China.
4. Department of Emergency Medicine, The Foshan First People's Hospital, Foshan 528000, China.
- Publication Type:Journal Article
- Keywords:
correlation analysis;
ischemic stroke with hypertension;
lipoprotein-associated phospholipase A2;
recurrence
- MeSH:
Humans;
Infant, Newborn;
1-Alkyl-2-acetylglycerophosphocholine Esterase;
Acute Disease;
Biomarkers;
Brain Ischemia/etiology*;
Case-Control Studies;
Cerebral Infarction;
Hypertension/complications*;
Ischemic Stroke/complications*;
Retrospective Studies;
Risk Factors;
Stroke
- From:
Journal of Southern Medical University
2023;43(2):317-322
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the relationship between serum lipoprotein-associated phospholipase A2 (Lp-PLA2) level and the risk of acute ischemic stroke (AIS) recurrence in hypertensive patients.
METHODS:This retrospective case-control study was conducted among 211 hypertensive patients with AIS treated in Foshan First People's Hospital, including 35 patients with recurrence of AIS during the 1-year follow-up as confirmed by head CT/MR. In the overall patients, 60 had grade 1 hypertension (including 5 recurrent cases), 76 had grade 2 hypertension (with 11 recurrent cases), and 75 had grade 3 hypertension (with 19 recurrent cases). Univariate analysis, multivariate logistic regression analysis, trend analysis, and smooth curve fitting analysis were performed to explore the correlation between serum Lp-PLA2 level within 24 h after admission and the risk of AIS recurrence. The predictive efficacy of serum Lp-PLA2 level for AIS recurrence in different hypertension grades was evaluated using ROC curve analysis.
RESULTS:Serum Lp-PLA2 level, age, NIHSS score at admission, mRS scores at 7 days, homocysteine level and smoking status differed significantly between patients with and without AIS recurrence (P < 0.05). After adjustment for confounding factors, multivariate regression analysis showed that the highest tertile of Lp-PLA2 level was associated with a 4.13-fold increase of AIS recurrence risk compared with the lowest tertile (OR=5.13, 95% CI: 1.35-19.40), and each 1 ng/mL increase of Lp-PLA2 level was associated with a 1% increase of AIS recurrence risk (OR= 1.01, 95% CI: 1.01-1.02). Serum Lp-PLA2 level was shown to positively correlate with AIS recurrence risk, and in patients with grade 3 hypertension, its areas under the ROC curve for predicting AIS recurrence was 0.869 with a specificity of 0.893 and a sensitivity of 0.737.
CONCLUSION:Serum Lp-PLA2 concentration is an independent risk factor and potentially an effective predictor for AIS recurrence in patients with grade 3 hypertension.
